Financials

Company Profile

Scorpius Holdings, Inc. is not engaged in any business activities. The Company was previously a contract development and manufacturing organization.

Employees

Sector

Date	Price	Change	Volume
29/10/26	USD 0.000600	0.00%	814

Delayed Quote OTC Markets

Market Closed - OTC Markets 06:14:59 30/10/26 am AEDT			5-day change	1st Jan Change
0.000600 ^USD	0.00%		+500.00%	+200.00%

25/04	Scorpius Holdings, Inc. Announces Board and Committee Changes	CI
08/04	Scorpius Holdings, Inc. Announces Resignation of William Ostrander as Chief Financial Officer, Effective March 31, 2026	CI

25/04	Scorpius Holdings, Inc. Announces Board and Committee Changes	CI
08/04	Scorpius Holdings, Inc. Announces Resignation of William Ostrander as Chief Financial Officer, Effective March 31, 2026	CI
11/03	Scorpius Holdings, Inc. announced that it has received $0.031175 million in funding	CI
26/02	Scorpius Holdings, Inc. announced that it has received $0.219544 million in funding	CI
18/02	Scorpius Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
12/02	Scorpius Holdings, Inc. announced that it has received $0.030427 million in funding	CI
13/01	Scorpius Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
16/12	Scorpius Holdings, Inc. announced that it has received $0.044374 million in funding	CI
11/12	Velocity Bioworks, Inc. acquired All of Personal Property and Assets of Scorpius Holdings, Inc. for $16.3 million.	CI
03/12	Scorpius Holdings, Inc. Announces Issuance of Multiple Non-Convertible Promissory Notes with Customary Terms	CI
01/12	Scorpius Holdings, Inc. announced that it has received $0.1541 million in funding	CI
26/11	Scorpius Holdings, Inc. announced that it has received $0.724523 million in funding	CI
25/11	Scorpius Holdings, Inc. announced that it has received $0.03795 million in funding	CI

02/05/23	Brookline Capital Downgrades NightHawk Biosciences to Hold From Buy	MT
03/04/23	Maxim Downgrades NightHawk Biosciences to Hold From Buy	MT
19/03/22	B. Riley Lowers Heat Biologics' PT to $8 from $10, Adjusts Model for Higher Cost of Capital to Support Higher Operating Expenditures Ramp; Keeps Buy Rating	MT
16/03/22	Alliance Global Adjusts Heat Biologics' Price Target to $15.50 From $20, Reiterates Buy Rating	MT
25/01/22	B. Riley Lowers Heat Biologics' Price Target to $10 from $15 After Revising Cost Capital Assumptions, Keeps Buy Rating	MT

13/01	Scorpius : Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q)	PU
15/11/24	Scorpius : Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability Form 8 K	PU
22/10/24	Scorpius Holdings Announces Partnership with U.S. Biotech Company	AQ
02/10/24	Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats	AQ
30/09/24	Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing Opportunities	AQ

Manager	Title	Age	Since
Jeff Wolf CEO	Chief Executive Officer	63	01/04/2010
Joe Payne COO	Chief Operating Officer	-	-
David Waldman IRC	Investor Relations Contact	-	-

Date	Insider	Type	Main position	Quantity	% Market Cap.	Importance
16/5/24	Jeff Wolf	Free	Chief Executive Officer	5,000,000	13.8766%
16/5/24	Seed-One Ventures LLC	Other	Company	0	0%	-
16/5/24	Orion Holdings LLC	Other	Company	0	0%	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SCORPIUS HOLDINGS, INC.	0.00%	+500.00%	-53.85%	-100.00%	36.68K
INVESTOR AB	-0.14%	+3.15%	+32.63%	+109.55%	132B
INDUSTRIVÄRDEN AB	-0.57%	+3.26%	+30.63%	+84.98%	22.89B
HAL TRUST	+0.12%	+1.80%	+24.82%	+61.29%	17.14B
MERITZ FINANCIAL GROUP INC.	+1.37%	+4.23%	+20.43%	+164.81%	16.07B
LUNDBERG B	-0.51%	+3.19%	+13.45%	+29.77%	14.69B
INVESTMENT AB LATOUR	+0.05%	+4.09%	-11.57%	+14.26%	14.08B
WASHINGTON H. SOUL PATTINSON AND COMPANY LIMITED	+0.39%	-0.93%	+21.31%	+35.90%	12.22B
BAJAJ HOLDINGS & INVESTMENT LIMITED	+0.69%	-8.54%	-17.89%	+50.24%	11.98B
KINGDOM HOLDING COMPANY	-1.08%	-1.81%	+53.94%	+66.39%	11.78B
Average	+0.03%	+1.06%	+11.39%	+51.72%	25.3B
Weighted average by Cap.	-0.06%	+2.35%	+25.62%	+89.26%